These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22465236)

  • 1. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.
    Cotten SW; Duncan DL; Burch EA; Seashore CJ; Hammett-Stabler CA
    Clin Biochem; 2012 Jun; 45(9):605-9. PubMed ID: 22465236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the Editor regarding a report about the potential for commonly used baby cleansers to interfere with cannabinoid (THC) immunoassays.
    Mays DA; McCarthy TJ
    Clin Biochem; 2012 Oct; 45(15):1266; author reply 1267. PubMed ID: 22884487
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoassay methods used to diagnose patients poisoned with psychoactive substances--analytical and interpretation problems].
    Gomółka E; Hydzik P; Madej T; Łata S; Rojek S
    Przegl Lek; 2012; 69(8):629-31. PubMed ID: 23243950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False positive drugs of abuse immunoassays.
    Kapur BM
    Clin Biochem; 2012 Jun; 45(9):603-4. PubMed ID: 22614002
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
    Uhl M; Sachs H
    Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassay cross-reactivity of phenylephrine and methamphetamine.
    Curtin LB; Cawley MJ
    Pharmacotherapy; 2012 May; 32(5):e98-102. PubMed ID: 22499397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reanalysis of forensic urine specimens containing benzoylecgonine and THC-COOH.
    Romberg RW; Past MR
    J Forensic Sci; 1994 Mar; 39(2):479-85. PubMed ID: 8195759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lowering confirmatory test cutoff value in pre-enlistment urine cannabinoids screening: about five years' experience in the French Gendarmerie.
    Lecompte Y; Perrin M; Salle S; Roussel O
    J Anal Toxicol; 2012 Oct; 36(8):569-74. PubMed ID: 22933660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industrial employee drug screening: a blind study of laboratory performance using commercially prepared controls.
    Knight SJ; Freedman T; Puskas A; Martel PA; O'Donnell CM
    J Occup Med; 1990 Aug; 32(8):715-21. PubMed ID: 2401928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of urine THC immunoassay in healthy volunteers receiving an oral proton-pump inhibitor.
    Vohra V; Marraffa JM; Wojcik SM; Eggleston W
    Clin Toxicol (Phila); 2020 Jun; 58(6):498-500. PubMed ID: 31566030
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.